Although barely detectable in healthy donors, EZH2 was upregulated in both AML1-ETO-positive and AML1-ETO-negative leukemia cells (see Fig. 1b), suggesting an AML1-ETO-independent mechanism. This evidence concerns the gene RUNX1T1 and leukemia.